We are live on ! Find out more
RGNX icon

Regenxbio
RGNX

177 hedge funds and large institutions have $325M invested in Regenxbio in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 58 increasing their positions, 50 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more call options, than puts

Call options by funds: $1.4M | Put options by funds: $494K

16% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 50

3.4% less ownership

Funds ownership: 88.36% → 84.96% (-3.4%)

5% less funds holding

Funds holding: 186 → 177 (-9)

11% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 44

29% less capital invested

Capital invested by funds: $458M → $325M (-$133M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
177
Holders Change
-9
Holders Change %
-4.84%
% of All Funds
2.33%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
39
Increased
58
Reduced
50
Closed
44
Calls
$1.4M
Puts
$494K
Net Calls
+$904K
Net Calls Change
+$6.06M

Top Buyers

1
JP Morgan Chase
JP Morgan Chase
New York
+$15.6M
2
Millennium Management
Millennium Management
New York
+$9.96M
3
Morgan Stanley
Morgan Stanley
New York
+$6.14M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$4.69M
5
Norges Bank
Norges Bank
Norway
+$4.22M

Top Sellers

1
BlackRock
BlackRock
New York
-$31.7M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$13M
3
APM
Avidity Partners Management
Texas
-$5.64M
4
State Street
State Street
Massachusetts
-$5.61M
5
ACM
Aquilo Capital Management
California
-$5.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
26
Aquilo Capital Management
California
$2.68M -$5.49M -584,406 -63%
VC
27
Voss Capital
Texas
$2.57M +$3.12M +332,814 New
Hudson Bay Capital Management
28
Hudson Bay Capital Management
Connecticut
$2.38M +$874K +93,100 +43%
Ameriprise
29
Ameriprise
Minnesota
$2.2M +$121K +12,883 +5%
SL
30
Siren LLC
Connecticut
$2.2M – – –
Bank of America
31
Bank of America
North Carolina
$2.17M -$1.55M -164,980 -37%
Renaissance Technologies
32
Renaissance Technologies
New York
$2.1M +$2.55M +271,300 New
AI
33
ArchPoint Investors
Florida
$1.71M -$25.8K -2,750 -1%
PAM
34
Panagora Asset Management
Massachusetts
$1.61M -$13.1K -1,393 -0.7%
Deutsche Bank
35
Deutsche Bank
Germany
$1.55M +$148K +15,722 +9%
UBS Group
36
UBS Group
Switzerland
$1.49M +$768K +81,818 +73%
JF
37
Jump Financial
Illinois
$1.49M +$1.07M +114,005 +145%
Stifel Financial
38
Stifel Financial
Missouri
$1.46M +$371K +39,564 +27%
Two Sigma Advisers
39
Two Sigma Advisers
New York
$1.39M +$1.05M +112,000 +165%
ACM
40
ADAR1 Capital Management
Texas
$1.32M -$3.75M -398,879 -70%
Jane Street
41
Jane Street
New York
$1.27M +$1.18M +126,135 +325%
HWAM
42
Hennion & Walsh Asset Management
New Jersey
$1.27M +$122K +13,014 +9%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$1.25M -$1.5M -159,253 -50%
TI
44
Trexquant Investment
Connecticut
$1.16M +$1.41M +150,022 New
Macquarie Group
45
Macquarie Group
Australia
$1.15M – – –
YIH
46
Y-Intercept (HK)
Hong Kong
$1.06M +$1.29M +137,402 New
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$1.04M +$1.02M +108,797 +423%
Barclays
48
Barclays
United Kingdom
$982K +$104K +11,041 +10%
Citigroup
49
Citigroup
New York
$887K +$181K +19,300 +20%
N
50
Nuveen
North Carolina
$868K – – –
1
2
3 4 5

RGNX Hedge Fund Activity: Q4 2024 in Review

177 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q4 2024, worth a combined $325M — down 29% from $458M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of RGNX and 39 opened new positions — a net loss of 5 holders — while 50 trimmed existing stakes and 58 added.

The largest buyer was JP Morgan Chase, adding an estimated $15.6M. The largest seller was BlackRock, cutting an estimated $31.7M.

  • 177 institutional investors held Regenxbio (RGNX) as of Q4 2024, down from 186 in Q3 2024.
  • Funds reported $325M of Regenxbio stock for Q4 2024, down 29% quarter-over-quarter.
  • 39 funds opened new Regenxbio positions in Q4 2024 and 44 closed out, a net change of -5 holders.
  • The largest Regenxbio buyer in Q4 2024 was JP Morgan Chase, an estimated $15.6M added.
  • The largest Regenxbio seller in Q4 2024 was BlackRock, an estimated $31.7M sold.

Based on aggregated 13F filings for Q4 2024.